yingweiwo

ACE

ACE

By making blood vessels tighten, the angiotensin-converting enzyme (ACE) indirectly raises blood pressure. Angiotensin I is changed by ACE into angiotensin II, which tightens the blood vessels. The renin-angiotensin system (RAS), which controls blood pressure by regulating the volume of fluids in the body, is made up of ACE, angiotensin I, and angiotensin II. Cells in the endothelium (inner layer) of blood vessels secrete ACE in the lungs and kidneys.It serves two main purposes: In a substrate concentration-dependent manner, ACE catalyzes the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. Bradykinin, a potent vasodilator, and other vasoactive peptides are broken down by ACE. In order to treat conditions like high blood pressure, heart failure, diabetic nephropathy, and type 2 diabetes mellitus, ACE inhibition is a goal. By inhibiting ACE (using ACE inhibitors), angiotensin II production and bradykinin metabolism are reduced, which causes a systematic dilation of the arteries and veins and a reduction in arterial blood pressure.

ACE related products

Structure Cat No. Product Name CAS No. Product Description
(±)8(9)-EpETE V87314 (±)8(9)-EpETE 851378-93-3 (±)8(9)-EpETE ((±)8,9-EEQ; (±)8,9-epoxy Eicosatetraenoic acid) can be converted to epoxyeicosatetraenoic acid (EpETE) by multiple cytochrome P450 isozymes.
4-羟基他莫昔芬 V16693 trans-4-Hydroxytamoxifen 68047-06-3 4-Hydroxytamoxifen ((Z)-4-Hydroxytamoxifen) is an orally bioavailable, selective estrogen receptor modulator (SERM).
Abz-LFK(Dnp)-OH V85768 Abz-LFK(Dnp)-OH 1217437-30-3
Abz-SDK(Dnp)P-OH V85747 Abz-SDK(Dnp)P-OH 860313-53-7
AC-SDKP-NH2 V120050 AC-SDKP-NH2 194484-75-8 AC-SDKP-NH2 is a substrate peptide of angiotensin-converting enzyme (ACE).
AD-012 V50469 AD-012 3010931-94-6 AD012 is a cACE/NEP dual inhibitor.
AD-013 V50460 AD-013 3010931-81-1 AD013 is a cACE/NEP dual inhibitor.
Alamandine V72991 Alamandine 1176306-10-7 Alamandine is a vasoactive peptide, a member of the renin-angiotensin system (RAS), and an endogenous ligand of the G protein-coupled receptor MrgD.
Angiotensin Converting Enzyme, Rabbit V109922 Angiotensin Converting Enzyme, Rabbit Rabbit angiotensin-converting enzyme (EC 3.4.15.1) indirectly raises blood pressure by causing vasoconstriction.
Angiotensin Converting Enzyme, Rat V110223 Angiotensin Converting Enzyme, Rat Rat angiotensin-converting enzyme (EC 3.4.15.1) indirectly raises blood pressure by causing vasoconstriction.
BKIDC-1553 V87311 BKIDC-1553 1951431-34-7 BKIDC-1553 is an orally available antiglycolytic agent and kinase inhibitor derivative with a predicted half-life of approximately 17 h in humans.
Canvircept V87319 Canvircept Canvircept is a monoclonal antibody against ACE2.
Casein hydrolysate V87321 Casein hydrolysate 65072-00-6 Casein hydrolysate is the hydrolysis product of casein.
CEI12 V111012 CEI12 26046-92-4 CEI12 is an angiotensin I converting enzyme inhibitor (ACEI) polypeptide that can be isolated from αs1-casein peptide.
Cilazapril hydrochloride V95275 Cilazapril hydrochloride 88824-78-6 Cilazapril hydrochloride is an angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension and congestive heart failure.
Cilazapril-d5 trifluoroacetate V120066 Cilazapril-d5 trifluoroacetate Cilapril-d5 (Ro 31-2848-d5) trifluoroacetate is a deuterated derivative of cilapril.
Cilazaprilat V87317 Cilazaprilat 90139-06-3 Cilazaprilat (Ro 31-3113) is an inhibitor of angiotensin-converting enzyme (ACE; IC50 = 0.7 nM for rat enzyme) and an active metabolite of Cilazapril.
Deserpidine hydrochloride V94258 Deserpidine hydrochloride 6033-69-8 Harmonyl hydrochloride is an antihypertensive compound that competitively inhibits the activity of angiotensin-converting enzyme (ACE).
Epicaptopril V100430 Epicaptopril 63250-36-2 Ecaptopril (SQ 14534) is a derivative of captopril.
HOE-288 V116033 HOE-288 93231-79-9 HOE-288 is an orally effective angiotensin-converting enzyme (ACE) inhibitor.
Contact Us